SCHEMBL16881353

SCHEMBL16881353

CCOC(=O)c1cncc(Cc2cccnc2CNC(=O)OC(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 2/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MAPT P10636 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ SCN2A Q99250 1/20 0.37
▸ SCN10A Q9Y5Y9 1/20 0.37
▸ KLKB1 P03952 1/20 0.37
▸ KLK1 P06870 1/20 0.37
▸ AKT1 P31749 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ P2RY12 Q9H244 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16881402 0.89 NAMPT (0.45) NAMPTCYP3A4SCN2ASCN10AKLKB1
SCHEMBL16880569 0.88 CYP2C9 (0.43) NAMPTKMT2APOLBGAACYP3A4
SCHEMBL509278 0.82 CYP2C19 (0.51) NAMPTKMT2APOLBGAACYP3A4
SCHEMBL16881041 0.75 NAMPT (0.43) NAMPTKMT2ACYP3A4ALDH1A1SCN2A
SCHEMBL31098519 0.74 BRD4 (0.50) NAMPTCYP3A4MAPTAKT1NPC1
SCHEMBL16881468 0.74 CYP2C9 (0.45) KMT2APOLBGAACYP3A4CYP2C9
SCHEMBL29907709 0.74 NAMPT (0.47) NAMPTCYP3A4AKT1KDM4E
SCHEMBL21730231 0.74 NAMPT (0.47) NAMPTCYP3A4AKT1KDM4E
SCHEMBL1631864 0.74 ADORA2A (0.48) NAMPTCYP3A4AKT1ADORA2A
SCHEMBL12663061 0.73 NAMPT (0.44) NAMPTCYP3A4AKT1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106061480-B Therapeutic inhibitory compounds 莱福斯希医药公司 2020-02-28 — — CN disclosed
EP-3089746-A1 THERAPEUTIC INHIBITORY COMPOUNDS Lifesci Pharmaceuticals, Inc. (BB) 2016-11-09 — — EP disclosed
CN-106061480-A Therapeutic inhibitory compounds 莱福斯希医药公司 2016-10-26 — — CN disclosed
WO-2015103317-A1 THERAPEUTIC INHIBITORY COMPOUNDS LIFESCI PHARMACEUTICALS, INC. (BB) 2015-07-09 — — WO disclosed
Send feedback